Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas.

作者: G. M. Brodeur , B. Vogelstein , S. E. Kern , P. S. White , A. B. Cantor

DOI:

关键词:

摘要: Neuroblastomas have been characterized genetically by N- myc amplification and deletions or loss of heterozygosity (LOH) for the short arm chromosome 1. However, recent studies suggested deletion allelic involving at least three other arms, 11q, 14q, 17p. Therefore, we undertook an analysis these respective chromosomal arms to determine frequency pattern LOH as well correlation findings with biological clinical variables. A group 24 pairs normal tumor DNAs was chosen that were representative patients different ages stages. substantial (≥20%) found only 1p whereas occurred in ≤5% cases. On basis results, extended a total 59 neuroblastomas, 15 cases (25%) 14q 10 43 informative (23%). (25%). This confirmed almost exclusively advanced stages disease. Furthermore, usually independent each other, frequently associated amplification, not. Thus, our results demonstrate neuroblastomas are complex there two distinct loci putative suppressor genes deleted independently this tumor, both which

参考文章(18)
Garrett M. Brodeur, Eric J. Stanbridge, Clare Fasching, Scott A. Bader, Dissociation of suppression of tumorigenicity and differentiation in vitro effected by transfer of single human chromosomes into human neuroblastoma cells. Cell Growth & Differentiation. ,vol. 2, pp. 245- 255 ,(1991)
Hideo Mugishima, Masaaki Terada, Ikuo Okabe, Takashi Sugimura, Masahiko Ookuni, Takashi Suzuki, Jun Yokota, Frequent loss of heterozygosity on chromosome 14q in neuroblastoma. Cancer Research. ,vol. 49, pp. 1095- 1098 ,(1989)
G. M. Brodeur, G. S. Sekhon, M. N. Goldstein, Chromosomal aberrations in human neuroblastomas. Cancer. ,vol. 40, pp. 2256- 2263 ,(1977) , 10.1002/1097-0142(197711)40:5<2256::AID-CNCR2820400536>3.0.CO;2-1
Ted Gansler, Jane Chatten, Michael Varello, Greta R. Bunin, BARBARA Atkinson, Flow cytometric DNA analysis of neuroblastoma. Correlation with histology and clinical outcome Cancer. ,vol. 58, pp. 2453- 2458 ,(1986) , 10.1002/1097-0142(19861201)58:11<2453::AID-CNCR2820581117>3.0.CO;2-I
H Christiansen, F Lampert, Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastoma. British Journal of Cancer. ,vol. 57, pp. 121- 126 ,(1988) , 10.1038/BJC.1988.24
A. Thomas Look, F. Ann Hayes, Ruprecht Nitschke, Nancy B. McWilliams, Alexander A. Green, Cellular DNA Content as a Predictor of Response to Chemotherapy in Infants with Unresectable Neuroblastoma New England Journal of Medicine. ,vol. 311, pp. 231- 235 ,(1984) , 10.1056/NEJM198407263110405
Eric R. Fearon, Bert Vogelstein, A genetic model for colorectal tumorigenesis Cell. ,vol. 61, pp. 759- 767 ,(1990) , 10.1016/0092-8674(90)90186-I
Garrett M. Brodeur, Chin-to Fong, Molecular biology and genetics of human neuroblastoma Cancer Genetics and Cytogenetics. ,vol. 41, pp. 153- 174 ,(1989) , 10.1016/0165-4608(89)90243-4
G. Brodeur, R. Seeger, M Schwab, H. Varmus, J. Bishop, Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage Science. ,vol. 224, pp. 1121- 1124 ,(1984) , 10.1126/SCIENCE.6719137